FDA to start hearings on contraceptives

The Food and Drug Administration (FDA) will hold the first round of summary hearings in August to finalize the certification and re-certification of disputed contraceptive products under their amended rules.

FDA’s change in their screening process was made for the first time due to the Supreme Court (SC) decision on August 24, 2016 directing them to “formulate the rules of procedure in the screening, evaluation and approval of all contraceptive drugs and devices that will be used under Republic Act No. 10354 [Reproductive Health Law].”